Apellis Pharmaceuticals (APLS) Earnings Call Transcripts

Price: $19.61
Market Cap: $2.46B
Avg Volume: 1.93M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.844
52W Range: $17.72-57.85
Website: Apellis Pharmaceuticals
Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-28 $-0.37 $-0.29
Read Transcript Q3 2024 2024-11-05 $-0.32 $-0.46
Read Transcript Q2 2024 2024-08-01 $-0.33 $-0.28
Read Transcript Q1 2024 2024-05-07 $-0.54 $-0.54
Read Transcript Q4 2023 2024-02-27 $-0.66 $-0.73
Read Transcript Q3 2023 2023-11-01 $-0.84 $-1.17
Read Transcript Q2 2023 2023-07-31 $-1.35 $-1.02
Read Transcript Q1 2023 2023-05-06 N/A N/A
Read Transcript Q3 2022 2022-11-08 N/A N/A
Read Transcript Q2 2022 2022-08-08 $-1.43 $-1.46
Read Transcript Q1 2022 2022-05-04 $-1.36 $-1.42
Read Transcript Q4 2021 2022-02-28 $-1.32 $-1.61
Read Transcript Q3 2021 2021-11-08 $-1.73 $-2.28
Read Transcript Q2 2021 2021-08-10 N/A N/A
Read Transcript Q1 2021 2021-04-29 N/A N/A
Read Transcript Q4 2020 2021-02-28 N/A N/A

Related Metrics

Explore detailed financial metrics and analysis for APLS.